Neuropathologic evaluation remains the """"""""gold standard"""""""" for identifying the cause(s) of dementia. The major responsibilities of this Core are to perform the neuropathologic studies necessary to document the diagnosis of Alzheimer disease (AD) and/or other pathologic entities in all human brain specimens used in research studies proposed by investigators within and outside of the ADC, and to provide clinico-pathologic correlation for ADC Clinical Core patients. Therefore, in Specific Aim 1, we will maintain a human brain tissue bank whose mail functions will be: 1) to collect, prepare, evaluate (including ApoE genotyping), catalog, store, and distribute well-characterized postmortem brain tissue and other samples (including postmortem DNA) from deceased demented and control subjects for use in research;2) to report qualitative and quantitative diagnostic information to physicians, families, and researchers;3) to work with the Clinical Core to provide clinico-pathologic correlation;and 4) to regularly update the central ADC and National Alzheimer Coordinating Center (NACC) databases with diagnostic and other related information on autopsied and biopsied subjects. In order to enhance the neuropathologic characterization of brain tissue accessioned through this Core, in Specific Aim 2, we will also focus on providing extensive quantitative neuropathologic evaluations for correlation with clinical and research data. The specific analyses to be performed will include: 1) ongoing quantification of synapse density (by measuring concentration of synaptophysin) in postmortem neocortex using an enzyme-linked immunosorbant assay (ELISA) the we developed;2) quantification of neocortical neuritic dystrophy in sections immunostained for tau and alpha-synuclein using optimized, highly sensitive and specific immunostaining techniques and computer assisted light microscopic image analysis;and 3) quantification of brain microvascular alterations, including blood vessel amyloid deposition and arteriosclerosis/lipohyalnosis and cerebral white matter density, using immunostaining and computer assisted light microscopic image analysis. The thorough neuropathologic characterization of brain tissue as proposed in this Core, utilizing a novel combination of state-of-the-art staining techniques and quantitative analyses, will provide the highest level of diagnostic certainty attainable, and ensure that appropriate tissues are used for research projects.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Center Core Grants (P30)
Project #
5P30AG012300-16
Application #
7798993
Study Section
Special Emphasis Panel (ZAG1)
Project Start
Project End
Budget Start
2009-04-01
Budget End
2010-03-31
Support Year
16
Fiscal Year
2009
Total Cost
$248,600
Indirect Cost
Name
University of Texas Sw Medical Center Dallas
Department
Type
DUNS #
800771545
City
Dallas
State
TX
Country
United States
Zip Code
75390
Schaffert, Jeff; LoBue, Christian; White, Charles L et al. (2018) Traumatic brain injury history is associated with an earlier age of dementia onset in autopsy-confirmed Alzheimer's disease. Neuropsychology 32:410-416
Rosenberg, Roger N; Fu, Min; Lambracht-Washington, Doris (2018) Intradermal active full-length DNA A?42 immunization via electroporation leads to high anti-A? antibody levels in wild-type mice. J Neuroimmunol 322:15-25
Davis, Jeremy J (2018) Performance validity in older adults: Observed versus predicted false positive rates in relation to number of tests administered. J Clin Exp Neuropsychol 40:1013-1021
Lin, Ming; Gong, Pinghua; Yang, Tao et al. (2018) Big Data Analytical Approaches to the NACC Dataset: Aiding Preclinical Trial Enrichment. Alzheimer Dis Assoc Disord 32:18-27
Kirson, Noam Y; Scott Andrews, J; Desai, Urvi et al. (2018) Patient Characteristics and Outcomes Associated with Receiving an Earlier Versus Later Diagnosis of Probable Alzheimer's Disease. J Alzheimers Dis 61:295-307
Crum, Jana; Wilson, Jeffrey; Sabbagh, Marwan (2018) Does taking statins affect the pathological burden in autopsy-confirmed Alzheimer's dementia? Alzheimers Res Ther 10:104
Pottier, Cyril; Zhou, Xiaolai; Perkerson 3rd, Ralph B et al. (2018) Potential genetic modifiers of disease risk and age at onset in patients with frontotemporal lobar degeneration and GRN mutations: a genome-wide association study. Lancet Neurol 17:548-558
Burke, Shanna L; Cadet, Tamara; Maddux, Marlaina (2018) Chronic Health Illnesses as Predictors of Mild Cognitive Impairment Among African American Older Adults. J Natl Med Assoc 110:314-325
Weintraub, Sandra; Besser, Lilah; Dodge, Hiroko H et al. (2018) Version 3 of the Alzheimer Disease Centers' Neuropsychological Test Battery in the Uniform Data Set (UDS). Alzheimer Dis Assoc Disord 32:10-17
Kamara, Dennis M; Gangishetti, Umesh; Gearing, Marla et al. (2018) Cerebral Amyloid Angiopathy: Similarity in African-Americans and Caucasians with Alzheimer's Disease. J Alzheimers Dis 62:1815-1826

Showing the most recent 10 out of 385 publications